Papers
2
Total Citations
29
H-Index
2
About
Yanwu Zhou is a leading thoracic surgeon whose research centers on the intersection of advanced surgical robotics and multimodal cancer therapy for non-small cell lung cancer (NSCLC). His work has been pivotal in establishing the feasibility and safety of robotic-assisted thoracic surgery (RATS) for complex patient populations. In his landmark 2022 prospective cohort study, Zhou demonstrated that RATS following neoadjuvant chemoimmunotherapy is not only technically viable but also associated with favorable perioperative outcomes in stage III NSCLC—a notoriously heterogeneous and challenging disease. This study, with 24 citations, has helped reshape clinical thinking about surgical candidacy after immunotherapy. More recently, Zhou has pioneered the integration of RATS into day surgery units, showing that select thoracic procedures can be safely performed in an ambulatory setting. This 2023 work, with 5 citations, reflects his commitment to reducing hospital stays and improving patient recovery. By systematically validating robotic approaches in both neoadjuvant and outpatient contexts, Zhou is driving a paradigm shift toward less invasive, more accessible thoracic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2Day surgery unit robotics thoracic surgery: feasibility and management5 citations · 2023